Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Clinical Research Fellow at Dana-Farber Cancer Institute, Visiting Professor at McGill University, shared a post on X:
“High quality RWD to fill a relevant evidence gap: among 501 young (≤40) patients with node-positive, ER+ breast cancer who had received 5y of OFS, extending ET beyond year 5 was associated with better IBCFS & DRFS. Led by super Carmine Valenza.”
Title: Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study
Authors: Carmine Valenza, Yue Zheng, Monica Milano, Dario Trapani, Elisa Giordano, Lorenzo Guidi, Pier Paolo Maria Berton Giachetti, Laura Boldrini, Grazia Castellano, Jalissa Katrini, Bianca Malagutti, Gabriele Antonarelli, Fabio Conforti, Eleonora Pagan, Vincenzo Bagnardi, Gregory J. Kirkner, Claudia Sangalli, Kate E. Dibble, Marco Colleoni, Meredith M. Regan, Elisabetta Munzone, Giuseppe Curigliano, Ann H. Partridge
Read the Full Article.
More posts featuring Paolo Tarantino.